Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 51,951 | 63,723 | 58,443 | 51,494 | 43,522 |
| Cost of Goods | 6,574 | 5,626 | 5,281 | 4,540 | 4,406 |
| Gross Profit | 45,377 | 58,097 | 53,162 | 46,954 | 39,116 |
| Operating Expenses | 315,968 | 230,504 | 135,825 | 126,148 | 117,559 |
| Operating Income | -270,017 | -171,781 | -82,382 | -78,654 | -78,037 |
| Interest Expense | 11,835 | 13,577 | 11,338 | 7,022 | 6,671 |
| Other Income | 15,913 | -8,148 | 12,984 | 14,638 | 78,155 |
| Pre-tax Income | -265,939 | -193,506 | -80,736 | -71,038 | -6,553 |
| Net Income Continuous | -265,939 | -193,506 | -80,736 | -71,038 | -6,553 |
| Net Income | $-265,939 | $-193,506 | $-80,736 | $-71,038 | $-6,553 |
| EPS Basic Total Ops | -1.42 | -1.22 | -1.01 | -0.92 | -0.09 |
| EPS Basic Continuous Ops | -1.42 | -1.22 | -1.01 | -0.92 | -0.09 |
| EPS Diluted Total Ops | -1.42 | -1.22 | -1.02 | -0.97 | -0.98 |
| EPS Diluted Continuous Ops | -1.42 | -1.22 | -0.94 | -0.86 | -0.08 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.08 | -1.13 | -0.97 | -0.98 |
| EBITDA(a) | $-265,694 | $-167,995 | $-79,399 | $-76,545 | $-75,616 |